Allelica to provide multi-ancestry polygenic risk score to Baylor College of Medicine for clinical implementation
NEW YORK, March 19, 2024 /PRNewswire/ -- Allelica, market leader in clinical solutions for polygenic risk score analysis and reporting, has announced a strategic collaboration with leading health sciences institution, Baylor College of Medicine (BCM), to integrate clinical, multi-ancestry polygenic risk score (PRS) testing into BCM's extensive patient services portfolio.
- NEW YORK, March 19, 2024 /PRNewswire/ -- Allelica, market leader in clinical solutions for polygenic risk score analysis and reporting, has announced a strategic collaboration with leading health sciences institution, Baylor College of Medicine (BCM), to integrate clinical, multi-ancestry polygenic risk score (PRS) testing into BCM's extensive patient services portfolio.
- This marks a significant milestone in making world class genomic medicine accessible, equitable, and impactful for patients across diverse communities.
- Allelica's PRS solution enables more precise identification of patients' genetic risk for coronary artery disease and other diseases and traits.
- Baylor is one of several institutions working with Allelica to provide clinical PRS testing to patients.